- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07344012
Parental Project Amongst 93 Patients With Turner Syndrome (TURNER)
January 7, 2026 updated by: University Hospital, Strasbourg, France
The aim is to describe the parental project, spontaneous pregnancies and pregnancies resulting from egg donation or adoption in women diagnosed with Turner syndrome treated at Strasbourg University Hospitals.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Estimated)
93
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Thibault BAHOUGNE, MD
- Phone Number: 33 3.88.12.78.99
- Email: thibault.bahougne@chru-strasbourg.fr
Study Locations
-
-
-
Strasbourg, France, 67091
- Recruiting
- Service d'Endocrinologie, Diabétologie, Nutrition - CHU de Strasbourg - France
-
Contact:
- Thibault BAHOUGNE, MD
- Phone Number: 33 3.88.12.78.99
- Email: thibault.bahougne@chru-strasbourg.fr
-
Principal Investigator:
- Thibault BAHOUGNE, MD
-
Sub-Investigator:
- Nathalie JEANDIDIE, MD
-
Sub-Investigator:
- Olivier PIRRELLO, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Adult women having presented with Turner syndrome confirmed by karyotyping and having expressed a desire to become a parent during consultation
Description
Inclusion Criteria:
- Adult women (≥18 years old)
- Treated at Strasbourg University Hospitals for a parental project during the period from January 1, 2009, to December 31, 2019
- Having presented with Turner syndrome confirmed by karyotyping
- Having expressed a desire to become a parent during consultation
Exclusion Criteria:
- No desire to become a parent or missing data
- Missing data
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Success rate of the parental project among patients with Turner syndrome who expressed a desire to become parents
Time Frame: Up to 24 months
|
Success rate of the parental project among patients with Turner syndrome who expressed a desire to become parents: Example: If 10 women try to have a child and 3 succeed, the success rate is 30%. |
Up to 24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 18, 2025
Primary Completion (Estimated)
November 1, 2027
Study Completion (Estimated)
November 18, 2027
Study Registration Dates
First Submitted
January 7, 2026
First Submitted That Met QC Criteria
January 7, 2026
First Posted (Actual)
January 15, 2026
Study Record Updates
Last Update Posted (Actual)
January 15, 2026
Last Update Submitted That Met QC Criteria
January 7, 2026
Last Verified
January 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Endocrine System Diseases
- Cardiovascular Diseases
- Male Urogenital Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Heart Diseases
- Genetic Diseases, Inborn
- Gonadal Disorders
- Congenital Abnormalities
- Cardiovascular Abnormalities
- Heart Defects, Congenital
- Disorders of Sex Development
- Urogenital Abnormalities
- Sex Chromosome Disorders
- Chromosome Disorders
- Sex Chromosome Disorders of Sex Development
- Gonadal Dysgenesis
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities
- Turner Syndrome
Other Study ID Numbers
- 9945 (Ohio State University Medical Center)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Turner Syndrome
-
University of Colorado, DenverCompletedTurner Syndrome | Turner Syndrome Mosaicism, 45, X/46, XX or XY | Turner Syndrome Mosaicism 46,X,I(X)(Q10)/45,X | Turner Syndrome Karyotype 46,X With Abnormal Sex Chromosome , Except I(Xq)United States
-
Ferring PharmaceuticalsTerminated
-
Merck KGaA, Darmstadt, GermanyCompletedGrowth Hormon Deficiency | Turner Syndrome in Pre-pubertal Children
-
Novo Nordisk A/SActive, not recruitingSGA, Turner Syndrome, Noonan Syndrome, ISSUnited States, United Kingdom, China, Thailand, Netherlands, Belgium, France, Ireland, Spain, Italy, India, Lithuania, Portugal, Malaysia, Greece, Saudi Arabia, Japan, Poland, Serbia, Germany, Slovenia, Switzerland, Austria, Brazil, Canada and more
-
University of AarhusAarhus University HospitalEnrolling by invitationSex Chromosome DisordersDenmark
-
Dong-A ST Co., Ltd.Completed
-
Radboud University Medical CenterPrincess Beatrix Muscle FoundationCompletedParsonage Turner Syndrome | Neuralgic Amyotrophy | Neuralgic Amyotrophy, Hereditary | Brachial NeuritisNetherlands
-
University of ChicagoJohns Hopkins University; Massachusetts General Hospital; Novo Nordisk A/S; University... and other collaboratorsTerminated
-
National Institute of Neurological Disorders and...Jefferson Medical College of Thomas Jefferson UniversityCompletedTurner's SyndromeUnited States
-
Sequenom, Inc.Friends Research Institute, Inc.TerminatedDown Syndrome | Turner Syndrome | Edwards Syndrome | Patau SyndromeUnited States